AIM: To investigate how clinically well, term newborns at risk of early-onset Group B streptococcal (EOGBS) disease are currently managed in the United Kingdom (UK). METHODS: Review of guidelines of UK neonatal units. RESULTS: One hundred and twenty-five guidelines covering 157 neonatal units were received (71% of UK units), three of which were excluded from the review. We found great variation in every aspect for the management of EOGBS disease risk including the following: definition of risk factors; management of at-risk newborns; choice of antibiotics. CONCLUSION: Our findings highlight the need for national consensus guidelines and clinical trials into the management of risk babies at risk of EOGBS disease.
AIM: To investigate how clinically well, term newborns at risk of early-onset Group B streptococcal (EOGBS) disease are currently managed in the United Kingdom (UK). METHODS: Review of guidelines of UK neonatal units. RESULTS: One hundred and twenty-five guidelines covering 157 neonatal units were received (71% of UK units), three of which were excluded from the review. We found great variation in every aspect for the management of EOGBS disease risk including the following: definition of risk factors; management of at-risk newborns; choice of antibiotics. CONCLUSION: Our findings highlight the need for national consensus guidelines and clinical trials into the management of risk babies at risk of EOGBS disease.
Authors: Diny G E Kolkman; Marlies E B Rijnders; Maurice G A J Wouters; M Elske van den Akker-van Marle; Cpb Kitty van der Ploeg; Christianne J M de Groot; Margot A H Fleuren Journal: BMC Pregnancy Childbirth Date: 2013-07-30 Impact factor: 3.007